NCT02962401
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Project manager Tours, France
Clinical trial condition
Waldenstrom Macroglobulinemia
Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.
108 public trials
22 recruiting studies
Waldenstrom Macroglobulinemia trial results
NCT03364231
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- TG Therapeutics Investigational Trial Site Washington D.C., District of Columbia, United States
- TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
- TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States
- TG Therapeutics Investigational Trial Site New York, United States
NCT00783367
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
- Locations
-
- University of Pennsylvania; Abramson Cancer Center; Lymphoma Program Philadelphia, Pennsylvania, United States
NCT02257242
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
- Locations
-
- Rhode Island Hospital and The Miriam Hospital Providence, Rhode Island, United States
Completed
Nonmyeloablative Allogeneic Transplant
NCT01272817
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adenocarcinoma, +91 more
- Locations
-
- Scripps Green Hospital La Jolla, California, United States
NCT01261247
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +66 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
Completed
Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia
NCT02677324
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford University Palo Alto, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Weill Cornell Medical College New York, United States
NCT02669017
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +39 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT01075321
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +59 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
Completed
Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
NCT01109069
- Conditions
- B Cell Lymphoma, B-Cell Diffuse Lymphoma, B-cell Chronic Lymphocytic Leukemia, +41 more
- Locations
-
- Stanford University Stanford, California, United States
- Stanford, California, United States
- University of Chicago Chicago, Illinois, United States
- Boston, Massachusetts, United States